These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 3117025)

  • 1. Müller's cell involvement in proliferative diabetic retinopathy.
    Nork TM; Wallow IH; Sramek SJ; Anderson G
    Arch Ophthalmol; 1987 Oct; 105(10):1424-9. PubMed ID: 3117025
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunohistochemical characterization of retinal glial cell changes in areas of vascular occlusion secondary to diabetic retinopathy.
    Bek T
    Acta Ophthalmol Scand; 1997 Aug; 75(4):388-92. PubMed ID: 9374245
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunocytochemical study of an eye with proliferative vitreoretinopathy and retinal tacks.
    Nork TM; Wallow IH; Sramek SJ; Stevens TS; De Venecia G
    Retina; 1990; 10(1):78-85. PubMed ID: 1971453
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Altered expression of retinal occludin and glial fibrillary acidic protein in experimental diabetes. The Penn State Retina Research Group.
    Barber AJ; Antonetti DA; Gardner TW
    Invest Ophthalmol Vis Sci; 2000 Oct; 41(11):3561-8. PubMed ID: 11006253
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of glial involvement in proliferative diabetic retinopathy.
    Ohira A; de Juan E
    Ophthalmologica; 1990; 201(4):187-95. PubMed ID: 2077455
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endothelin-1 is associated with fibrosis in proliferative diabetic retinopathy membranes.
    Chang W; Lajko M; Fawzi AA
    PLoS One; 2018; 13(1):e0191285. PubMed ID: 29351334
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vascular endothelial growth factor is present in glial cells of the retina and optic nerve of human subjects with nonproliferative diabetic retinopathy.
    Amin RH; Frank RN; Kennedy A; Eliott D; Puklin JE; Abrams GW
    Invest Ophthalmol Vis Sci; 1997 Jan; 38(1):36-47. PubMed ID: 9008628
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vascular damage in a mouse model of diabetic retinopathy: relation to neuronal and glial changes.
    Feit-Leichman RA; Kinouchi R; Takeda M; Fan Z; Mohr S; Kern TS; Chen DF
    Invest Ophthalmol Vis Sci; 2005 Nov; 46(11):4281-7. PubMed ID: 16249509
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunocytochemical identification of Müller's glia as a component of human epiretinal membranes.
    Guérin CJ; Wolfshagen RW; Eifrig DE; Anderson DH
    Invest Ophthalmol Vis Sci; 1990 Aug; 31(8):1483-91. PubMed ID: 2387681
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lowered cortistatin expression is an early event in the human diabetic retina and is associated with apoptosis and glial activation.
    Carrasco E; Hernández C; de Torres I; Farrés J; Simó R
    Mol Vis; 2008 Aug; 14():1496-502. PubMed ID: 18709137
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Retina-specific expression of PDGF-B versus PDGF-A: vascular versus nonvascular proliferative retinopathy.
    Mori K; Gehlbach P; Ando A; Dyer G; Lipinsky E; Chaudhry AG; Hackett SF; Campochiaro PA
    Invest Ophthalmol Vis Sci; 2002 Jun; 43(6):2001-6. PubMed ID: 12037011
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Müller cell changes in human diabetic retinopathy.
    Mizutani M; Gerhardinger C; Lorenzi M
    Diabetes; 1998 Mar; 47(3):445-9. PubMed ID: 9519752
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selective loss of S-cones in diabetic retinopathy.
    Cho NC; Poulsen GL; Ver Hoeve JN; Nork TM
    Arch Ophthalmol; 2000 Oct; 118(10):1393-400. PubMed ID: 11030822
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased expression of placenta growth factor in proliferative diabetic retinopathy.
    Khaliq A; Foreman D; Ahmed A; Weich H; Gregor Z; McLeod D; Boulton M
    Lab Invest; 1998 Jan; 78(1):109-16. PubMed ID: 9461127
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunolocalisation of the VEGF receptors FLT-1, KDR, and FLT-4 in diabetic retinopathy.
    Smith G; McLeod D; Foreman D; Boulton M
    Br J Ophthalmol; 1999 Apr; 83(4):486-94. PubMed ID: 10434875
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epiretinal membrane of proliferative diabetic retinopathy: an immunohistochemical study.
    Hosoda Y; Okada M; Matsumura M; Ogino N; Honda Y; Nagai Y
    Ophthalmic Res; 1993; 25(5):289-94. PubMed ID: 8259261
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neurochemical architecture of the normal and degenerating rat retina.
    Fletcher EL; Kalloniatis M
    J Comp Neurol; 1996 Dec; 376(3):343-60. PubMed ID: 8956104
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Roles of vascular endothelial growth factor and astrocyte degeneration in the genesis of retinopathy of prematurity.
    Stone J; Chan-Ling T; Pe'er J; Itin A; Gnessin H; Keshet E
    Invest Ophthalmol Vis Sci; 1996 Feb; 37(2):290-9. PubMed ID: 8603833
    [TBL] [Abstract][Full Text] [Related]  

  • 19. VEGF localisation in diabetic retinopathy.
    Boulton M; Foreman D; Williams G; McLeod D
    Br J Ophthalmol; 1998 May; 82(5):561-8. PubMed ID: 9713066
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Localisation of endothelin-1 mRNA expression and immunoreactivity in the retina and optic nerve from human and porcine eye. Evidence for endothelin-1 expression in astrocytes.
    Ripodas A; de Juan JA; Roldán-Pallarés M; Bernal R; Moya J; Chao M; López A; Fernández-Cruz A; Fernández-Durango R
    Brain Res; 2001 Sep; 912(2):137-43. PubMed ID: 11532429
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.